Oncolytics Biotech's total assets for Q1 2026 were C$8.16M, an increase of 7.64% from the previous quarter. ONCY total liabilities were C$13.29M for the fiscal quarter, a 16.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.